Author:
Ohara Nobumasa,Kaneko Masanori,Sato Kazuhiro,Maruyama Ryoko,Furukawa Tomoyasu,Tanaka Junta,Kaneko Kenzo,Kamoi Kyuzi
Publisher
Springer Science and Business Media LLC
Reference18 articles.
1. Filippatos TD, Athyros VG, Elisaf MS. The pharmacokinetic considerations and adverse effects of DPP-4 inhibitors. Expert Opin Drug Metab Toxicol. 2014;10:787–812.
2. Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, Nauck M, Peters AL, Tsapas A, Wender R, Matthews DR. Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2015;38:140–9.
3. Kumamoto T, Matsuda T, Fukuda K, Machida K, Mizuno K, Inoue H. A case of drug-induced lung pneumonitis caused by sitagliptin. Kokyu. 2013;32:1082–5 (in Japanese).
4. Hanaka T, Imanaga T, Kawakami S, Ide H, Moriwaki A, Mukae H. A case of drug-induced lung injury caused by sitagliptin. Ann Jpn Respir Soc. 2014;3:594–8 (in Japanese).
5. Yajima T, Jingu D, Shoji M, Igarashi T, Watanabe H, Takahashi H. A case of drug-induced pneumonitis caused by vildagliptin. Ann Jpn Respir Soc. 2015;4:176–80 (in Japanese).
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献